Activating Compound | Comment | Organism | Structure |
---|---|---|---|
2-chloro-2'-deoxyadenosine | - |
Homo sapiens | |
AG-490 | - |
Homo sapiens | |
daidzein | - |
Homo sapiens | |
genistein | - |
Homo sapiens | |
okadaic acid | - |
Homo sapiens | |
PD-98059 | - |
Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
H-7 | reduces the enzyme activation caused by the addition of 2-chloro-2-deoxyadenosine | Homo sapiens | |
protein phosphatase lambda | - |
Homo sapiens | |
staurosporine | reduces the enzyme activation caused by the addition of 2-chloro-2-deoxyadenosine | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 2'-deoxyadenosine | Homo sapiens | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | ADP + 2'-deoxyadenosine 5'-phosphate | - |
? | |
ATP + 2'-deoxycytidine | Homo sapiens | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | ADP + 2'-deoxycytidine 5'-phosphate | - |
? | |
additional information | Homo sapiens | key enzyme in the deoxynucleoside salvage pathway and in the activation of numerous nucleoside analogues used in cancer and antiviral chemotherapy | ? | - |
? | |
NTP + 2-chloro-2'-deoxyadenosine | Homo sapiens | i.e. cladribine, activation of the pharmaceutically relevant substrate which is commonly used in the treatment of lymphoproliferative malignancies | NDP + 2-chloro-2'-deoxyadenosine 5'-phosphate | - |
? | |
NTP + 9-beta-D-arabinosyl 2-fluoroadenine | Homo sapiens | activation of the pharmaceutically relevant substrate which is commonly used in the treatment of lymphoproliferative malignancies | NDP + 9-beta-D-arabinosyl 2-fluoroadenine 5'-phosphate | - |
? | |
UTP + 2',3'-dideoxycytidine | Homo sapiens | i.e. zalcitabine, activation of the pharmaceutically relevant substrate which is used for the treatment of HIV infections | UDP + 2',3'-dideoxycytidine 5'-phosphate | - |
? | |
UTP + 2'-deoxy-3'-thiacytidine | Homo sapiens | i.e. lamivudine, activation of the pharmaceutically relevant substrate which is used for the treatment of HIV infections | UDP + 2'-deoxy-3'-thiacytidine 5'-phosphate | - |
? | |
UTP + 2'-deoxyadenosine | Homo sapiens | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | UDP + 2'-deoxyadenosine 5'-phosphate | - |
? | |
UTP + 2'-deoxycytidine | Homo sapiens | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | UDP + 2'-deoxycytidine 5'-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | phosphorylation of the enzyme involved in the regulation of enzyme activity | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
CCRF-CEM cell | - |
Homo sapiens | - |
EHEB cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 2'-deoxyadenosine | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | Homo sapiens | ADP + 2'-deoxyadenosine 5'-phosphate | - |
? | |
ATP + 2'-deoxycytidine | - |
Homo sapiens | ADP + 2'-deoxycytidine 5'-phosphate | - |
? | |
ATP + 2'-deoxycytidine | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | Homo sapiens | ADP + 2'-deoxycytidine 5'-phosphate | - |
? | |
additional information | key enzyme in the deoxynucleoside salvage pathway and in the activation of numerous nucleoside analogues used in cancer and antiviral chemotherapy | Homo sapiens | ? | - |
? | |
NTP + 2-chloro-2'-deoxyadenosine | i.e. cladribine, activation of the pharmaceutically relevant substrate which is commonly used in the treatment of lymphoproliferative malignancies | Homo sapiens | NDP + 2-chloro-2'-deoxyadenosine 5'-phosphate | - |
? | |
NTP + 9-beta-D-arabinosyl 2-fluoroadenine | activation of the pharmaceutically relevant substrate which is commonly used in the treatment of lymphoproliferative malignancies | Homo sapiens | NDP + 9-beta-D-arabinosyl 2-fluoroadenine 5'-phosphate | - |
? | |
UTP + 2',3'-dideoxycytidine | i.e. zalcitabine, activation of the pharmaceutically relevant substrate which is used for the treatment of HIV infections | Homo sapiens | UDP + 2',3'-dideoxycytidine 5'-phosphate | - |
? | |
UTP + 2'-deoxy-3'-thiacytidine | i.e. lamivudine, activation of the pharmaceutically relevant substrate which is used for the treatment of HIV infections | Homo sapiens | UDP + 2'-deoxy-3'-thiacytidine 5'-phosphate | - |
? | |
UTP + 2'-deoxyadenosine | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | Homo sapiens | UDP + 2'-deoxyadenosine 5'-phosphate | - |
? | |
UTP + 2'-deoxycytidine | rate-limiting reaction in the salvage of deoxyribonucleosides, supplying cells with deoxyribonucleotides for DNA replicative and repair synthesis | Homo sapiens | UDP + 2'-deoxycytidine 5'-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
dCK | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens | |
UTP | - |
Homo sapiens |